Good Afternoon, Sareum Holdings plc this week released a patent update, an AGM statement and a successful subscription raising £1.63m. We have published research on this which is attached and a snapshot of the research is below. The specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of autoimmune diseases and cancer yesterday released its AGM statement, in which it has reported that the final toxicology and safety studies required to f ....